WEBINAR

Adoptive T-cell therapy – Solutions for T-cell engineering and expansion

Adoptive T-cell therapy is a promising development in cancer immunotherapy and the number of clinical trials is rapidly increasing every year. However, method optimization is still necessary to produce T cells at large scale. In this webinar, we will discuss tools for improving the T-cell engineering and expansion process to maximize the therapeutic potential of patient-derived T cells.

The webinar will cover the following topics:

Efficient serum-free T-cell culture using LymphoONE™ Medium
Benefits of RetroNectin® stimulation to ensure a high proportion of naïve-like T cells
Footprint-free T-cell engineering
T-cell engineering using viral delivery

SPEAKER

Cornelia Hampe, PhD
Senior Product Manager
Takara Bio Europe

First Name:

Last Name:

Email Address:

Organization:

Country:

State:

Postal Code:

What are your main interests?

Please specify your research interests:

WEBINAR

Adoptive T-cell therapy – Solutions for T-cell engineering and expansion

SPEAKER

Section 3 title

Section 3 column 1

Section 3 column 2

Section 3 Column 3

Section 4 title

Section 5 title

Section 6 title

Section 7 video title